Stomach Neoplasms: all 2,914 studies
Page 25 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Long-term Follow-up Prognosis of Atrophic Gastritis After 3 YearsCompletedNCT01824953
- S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma PatientsCompletedNCT01824459Phase 3
- Postoperative Chemoradiotherapy With S-1 in Gastric CancerCompletedNCT01824004Phase 2
- Botulinum Toxin for Stomach Cancer TreatmentCompletedNCT01822210Phase 2
- Density of Neurons in the Stomach and Prognosis of Gastric AdenocarcinomaWithdrawnNCT01821196Not applicable
- Parenteral Fish Oil in Major Laparoscopic Abdominal SurgeryStatus unknownNCT01819961Phase 4
- Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric CancerCompletedNCT01815853Phase 3
- Her 2 Testing in Indian Patients With Gastric CancerTerminatedNCT01814345
- Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric CancerCompletedNCT01813994Not applicable
- Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction CancerTerminatedNCT01813253Phase 3
- A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in ChinaStatus unknownNCT01812876
- Multicenter Phase III Trial of Laparoscopic Sentinel Node BiopsyCompletedNCT01804998Not applicable
- XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of StomachStatus unknownNCT01798251Phase 2
- Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric CancerStatus unknownNCT01795027Phase 3
- Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJCompletedNCT01791374Phase 1
- The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric CancerStatus unknownNCT01787539Phase 2/3
- The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up StudyStatus unknownNCT01785537
- Study of S-1 Plus DC-CIK for Patients With Advanced Gastric CancerCompletedNCT01783951Phase 1/2
- Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")Status unknownNCT01779583
- A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment CharacteristicsCompletedNCT01775514
- Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric CancerStatus unknownNCT01774266
- Early Jejunostomy Nutrition Minimizes Time to ChemotherapyStatus unknownNCT01766765Phase 4
- A Study of KX2-391 With Paclitaxel in Patients With Solid TumorsStatus unknownNCT01764087Phase 1/2
- Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II TrialStatus unknownNCT01761461Phase 3
- Comparison of O-type Hybrid Knife and IT Knife in ESDCompletedNCT01760070Not applicable
- Surgicel® Fibrillar for Delayed Bleeding After ESDCompletedNCT01758965Not applicable
- Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric CancerStatus unknownNCT01757366Phase 2
- Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric CancerStatus unknownNCT01756183Phase 2
- Safety, Feasibility and Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Pilot StudyCompletedNCT01751880Not applicable
- XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)TerminatedNCT01748851Phase 3
- A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction CancerCompletedNCT01748773Phase 2
- Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction CancerStatus unknownNCT01747707Phase 2
- TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine TumorsCompletedNCT01747096Not applicable
- A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric CancerCompletedNCT01746771Phase 1/2
- Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric CancerCompletedNCT01743365Phase 2
- Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric CancerStatus unknownNCT01742806Not applicable
- Feasibility Study of Intraperitoneal PaclitaxelStatus unknownNCT01739894Phase 2
- A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerCompletedNCT01736410Phase 2
- Screening for Familial Gastric Cancer in First Degree RelativesTerminatedNCT01727908Not applicable
- Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1CompletedNCT01719549Phase 2
- Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric CancerStatus unknownNCT01718626Phase 2
- Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric CancerTerminatedNCT01716546Phase 1/2
- Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin ResistanceWithdrawnNCT01714622
- Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric CarcinomaCompletedNCT01711242Phase 2
- Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryTerminatedNCT01705340Phase 1
- Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer PatientsStatus unknownNCT01704664Not applicable
- Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal LesionsStatus unknownNCT01698190Not applicable
- Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total GastrectomyStatus unknownNCT01697943Phase 3
- First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaTerminatedNCT01697072Phase 3
- A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 SurgeryStatus unknownNCT01679340Phase 2
- Gastric Cancer Prevention in the Family Members by Helicobacter Pylori EradicationActive, not recruitingNCT01678027Phase 3
- Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer PatientsStatus unknownNCT01674959Phase 2
- S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric CancerCompletedNCT01671449Phase 3
- Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric CancerTerminatedNCT01665274Phase 2
- A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal CancerCompletedNCT01662869Phase 3
- Cremona Population-Based Gastric Tumors RegistryStatus unknownNCT01662739
- Gastric Cancer Screening and Alarm Symptoms in Early Gastric CancerStatus unknownNCT01659632
- Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric StasisCompletedNCT01659619Phase 2
- Quality of Life After Oesophageal or Gastric Cancer SurgeryCompletedNCT01657175Not applicable
- Compliance to ERAS After Gastric SurgeryCompletedNCT01653496Phase 2
- Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper EndoscopyCompletedNCT01653171Phase 4
- Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric CancersStatus unknownNCT01650766
- Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine TumorsTerminatedNCT01648465Phase 2
- Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer PatientsCompletedNCT01643811
- Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesCompletedNCT01643499Phase 1
- Early Recovery After Gastric Cancer SurgeryStatus unknownNCT01642953Phase 2
- Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and CarcinomaStatus unknownNCT01642797Not applicable
- Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric CancerStatus unknownNCT01637805Phase 1
- Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 DiabetesStatus unknownNCT01637350
- Observational Study of Perioperative Chemotherapy in Gastric CancerCompletedNCT01633203
- The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric CancerStatus unknownNCT01627119
- Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric CancerCompletedNCT01625702Not applicable
- A Comparative Study of Salvage Treatment With Combination of Docetaxel and EpirubicinCompletedNCT01624025Phase 2
- Concentration of S-1 Metabolites in Tear and Plasma of Patients Receiving TS-1Status unknownNCT01621919
- Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?Status unknownNCT01621451Phase 4
- Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsStatus unknownNCT01618474Phase 2
- Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric CancerCompletedNCT01617876
- A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2CompletedNCT01614522Phase 2
- PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric CancerCompletedNCT01613950Phase 1
- Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric CancerTerminatedNCT01611506Phase 1/2
- Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01)Status unknownNCT01609309Phase 3
- Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric CancerCompletedNCT01602406Phase 1
- A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerCompletedNCT01598077Phase 1
- A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal CancerCompletedNCT01590719Phase 2
- Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)Status unknownNCT01584336Phase 2
- Endomicroscopy and Gastric MALT-lymphomaCompletedNCT01583699Not applicable
- Efficacy and Safety of CO2 vs Room Air Insufflation During ESD for Gastric TumorCompletedNCT01579071Phase 4
- Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsCompletedNCT01576666Phase 1
- A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsCompletedNCT01576380Phase 2
- Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric CancerStatus unknownNCT01573468Phase 2
- Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT01561014Phase 1
- Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric CancerStatus unknownNCT01558947Phase 2
- Qualitative Research for Stage 4 Stomach Cancer and Their CaregiversStatus unknownNCT01549756
- Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric CancerCompletedNCT01544413Not applicable
- SOX as Adjuvant Chemotherapy for Resectable Gastric CancerStatus unknownNCT01542294Phase 1/2
- Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 DissectionStatus unknownNCT01534546Phase 3
- The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric CancerCompletedNCT01531452Phase 2
- Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)TerminatedNCT01528501Phase 2
- Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II DiabetesStatus unknownNCT01528059Phase 2/3
- The Efficacy of Health Partnership Program for Cancer PatientsStatus unknownNCT01527409Not applicable